Open Actively Recruiting

Micro-UltraSound In Cancer - Active Surveillance

About

Brief Summary

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

Primary Purpose
Diagnostic
Study Type
Interventional
Phase
Phase 2

Eligibility

Gender
Male
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy

Exclusion Criteria:

  • Men who cannot undergo a prostate MRI
  • Men who cannot undergo a prostate biopsy

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
23-001792
Category
Prostate Cancer
Contact
Ankush Sachdeva
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05558241
For detailed technical eligibility, visit ClinicalTrials.gov.